# Subagent: Levin assessor retry

- **Parent chat:** [let's do the same thing for mike levin's works that we did for darwin and thomps](../2026-10-31_1314_let-s-do-the-same-thing-for-mike-levin-s-works-that-we-did-f.md)
- **Started:** 2026-10-31 13:51 EDT (UTC-4) through 2026-11-01 02:00, then EST (UTC-5)
- **Last activity:** 2026-10-31 15:44 EDT (UTC-4) through 2026-11-01 02:00, then EST (UTC-5)
- **Final status:** error
- **Transcript ID:** `9125a4a6-8dd6-4620-8acb-52dc563ed9ee`

---

### 2026-10-31 13:51 — Turn 1 (User)

> Read and follow /Users/jdietz/Documents/GitHub/dev/delphisci/books/levin-papers/assessment/INSTRUCTIONS.md exactly. Your input batch is /Users/jdietz/Documents/GitHub/dev/delphisci/books/levin-papers/assessment/inputs/batch-1.json. Write your output to /Users/jdietz/Documents/GitHub/dev/delphisci/books/levin-papers/assessment/raw/gemini/batch-1.json. Do not write any other file.

**Assistant:**

**Fetching Data**

I'm currently parsing the rubric and source metadata from the specified JSON files. My next step is to cross-reference this information.

**Counting Claims**

I'm currently reviewing the claims within `batch-1.json`. My immediate focus is on accurately counting the total number of claims present to ensure a thorough analysis against the `INSTRUCTIONS.md`.

**Counting claims accurately**

I've successfully enumerated 45 claims across the specified batches. I am now meticulously cross-referencing these counts against the specific resolution criteria outlined in `INSTRUCTIONS.md` to ensure strict adherence to the defined standards.

**Defining Claim Types**

I'm refining how I classify claims, particularly distinguishing between those requiring novel experiments and those addressable with existing data. The operationalization aspect for cognitive claims is a key consideration, and I'm ensuring all `candidate_datasets` are verifiable public resources.

**Verifying Dataset URLs**

I'm now focusing on verifying the URLs for candidate datasets. I've identified a set of resolvable links for SPM and BETSE, and am in the process of confirming PlanMine's resource. This ensures all references are robust and accessible.

**Validating Resource Links**

I'm now systematically checking the URLs for candidate datasets, expanding my validation to include resources like Xenbase, TCGA/GDC, ChEMBL/PubChem, and BioModels, alongside direct paper DOIs.

**Validating Simulation Parameters**

I'm verifying the specific parameters used in the active inference simulation from the `2015-place` paper. This involves confirming the equations for the 8-cell model and ensuring the integration method aligns with the SPM toolbox.

**Simulating Convergence**

I've confirmed that the simulation parameters for the 8-cell model, including integration scheme and precisions, are fully detailed in the `2015-place` paper and readily available in SPM. This makes re-running the simulation a direct path to verifying convergence to the head-body-tail configuration.

**Evaluating Empirical Support**

I'm currently assessing whether model inversion claims offer distinct empirical predictions beyond standard dynamical systems or gene-regulatory models. For `levin-2015-place-03`, I'm concluding it's not empirically resolvable, as the claim appears tautological given its mathematical framing.

**Proving Convergence**

I'm confirming that the claim for `levin-2015-place-04` is a mathematical law, specifically within the scope of active-inference models of morphogenesis where cells share a generative model. The free-energy minimization directly guarantees convergence to the target form under these precise conditions.

**Testing Model Predictions**

I'm now investigating claim `levin-2015-place-05`. My focus is on verifying whether the active-inference simulation demonstrates that identical cells migrate and differentiate into distinct types, and if this outcome is indeed driven by ensemble free energy reduction as stated.

**Validating Simulation Outcomes**

I'm confirming that claim `levin-2015-place-05` is demonstrably resolvable. Re-running the 8-cell simulation using `spm_ADEM.m` and inspecting the trajectory of cell positions, signal expression, and variational free energy around step 8 fully supports the claimed head-body-tail morphology.

**Testing Signal Sensitivity**

I'm now analyzing claim `levin-2015-place-07`. I'm investigating how alterations to signal sensitivity in the active-inference model affect morphogenesis, specifically focusing on the proposed pharmacological manipulation predictions.

**Testing Signal Sensitivity**

I'm now exploring `levin-2015-place-07`, specifically the simulation's reproducibility and the biological predictions. While the simulation is immediately resolvable, mapping it to specific morphogens and finding public perturbation datasets for biological validation presents a challenge. My preliminary verdict is `partially-resolvable`.

**Refining Predictions**

I'm now examining claim `levin-2015-place-09`. I'm verifying if active-inference simulations can achieve pattern formation without an exogenous gradient, and I'm assessing the reproducibility of the observed outcomes when a gradient is introduced to determine the degree of resolution.

**Resolving Pattern Formation**

I'm now examining claim `levin-2015-place-09`, focusing on its reliance on exogenous gradients for pattern formation and the reproducibility of outcomes when gradients are reintroduced. My initial assessment indicates it's resolvable by simulating the model with and without the gradient term.

**Assessing Conceptual Framing**

I'm reviewing claims that equate non-genetic physiological dynamics with active inference. I'm evaluating if this framing offers empirical distinctions beyond standard dynamical systems, considering the possibility of `not-empirically-resolvable` or `partially-resolvable` based on the presence of empirical differences.

**Assessing Conceptual Framing**

I'm examining the framing of non-genetic physiological dynamics within active inference, assessing if it provides empirical distinctions over standard dynamical systems. For the planarian data, equating active inference with any non-genetic signaling-dependent patterning leads to a `not-empirically-resolvable` verdict, aligning with instructions. My attention now shifts to the *Girardia* paper.

**Evaluating Empirical Data**

I'm now focusing on the *Girardia* paper's claims regarding regeneration. I've identified that while some summary data exists, the raw experimental datasets and modeling code are not publicly available, indicating these claims are `not-empirically-resolvable` per instructions.

**Confirming Data Requirements**

I'm focusing on the *Girardia* paper's regeneration claims. For `levin-2015-girardia-01`, the requirement for raw image or landmark data from octanol-treated *G. dorotocephala* regeneration, or new assays, means this claim is currently `needs-new-data`.

**Investigating Girardia Data**

I'm examining the *Girardia* regeneration claims, specifically for `levin-2015-girardia-01` and `levin-2015-girardia-02`. The lack of publicly available raw data, including landmark coordinates and photographs, means these claims currently fall under `needs-new-data`.

**Evaluating Evolutionary Correlations**

I'm examining `levin-2015-girardia-03`. While I can re-compute the evolutionary distances, the raw morphometric data for correlating shapes with phylogeny isn't available, limiting this to `partially-resolvable`. I'm now considering the implications of this data gap.

**Comparing Phylogenetic Distances**

I'm continuing to evaluate `levin-2015-girardia-03`. I'm now recomputing evolutionary distances using GenBank rRNA sequences and testing their correlation with the reported frequencies. While this allows partial testing, verifying the raw morphological classifications would necessitate new experiments.

**Evaluating Girardia Data**

I'm now examining claim `levin-2015-girardia-03`. While I can re-compute evolutionary distances, the raw morphometric data for correlating shapes with phylogeny isn't available, limiting this to `partially-resolvable`. I'm now considering the implications of this data gap.

**Investigating Experimental Reproducibility**

I'm now analyzing `levin-2015-girardia-06`. The claim involves complex image analysis of DiBAC dye imaging data. Without access to the raw images or the specific image processing code, reproducing these results is not feasible, leading to a `needs-new-data` verdict.

**Checking Regeneration Data**

I'm now processing claims related to *Girardia* regeneration. Specifically for `levin-2015-girardia-06` and `levin-2015-girardia-07`, the lack of public access to longitudinal imaging data prevents reproduction, classifying them as `needs-new-data`.

**Reconfirming Data Gaps**

I'm now reassessing `levin-2015-girardia-09`. The agent-based model's claim about reproducing observed head shapes hinges on deactivating signaling cells, which requires specific landmark data and simulation code. As these are unavailable, the verdict remains `needs-new-data`.

**Re-examining Model Specifications**

I'm now focused on the *Girardia* agent-based model. While Section 2.8 and Figure S2 provide a framework with cell types and a boundary condition, the absence of the C++ code and the graphical representation of crucial parameters prevent exact re-implementation and exact testing of the reported L1/L2 ratios.

**Investigating Model Parameters**

I'm reviewing the *Girardia* agent-based model's parameters, specifically the 1/L2 aspect ratios. Without the original C++ code and precise initial coordinates or spring constants, exact replication is only partially constrained, leading to a `partially-resolvable` verdict. My focus now shifts to the conceptual claim about octanol-induced head-shape changes.

**Refining Data Verdicts**

I'm currently re-evaluating the distinction between `needs-new-data` and `not-empirically-resolvable` for the *Girardia* regeneration claims. My current assessment for `levin-2015-girardia-10` leans towards `needs-new-data`, as the claim's empirical assertion about discrete morphologies requires raw morphometric data to test.

**Testing Gap Junction Claims**

I'm now examining claims related to gap junction perturbation in *G. dorotocephala* regeneration. The lack of publicly available raw morphometric and bioelectric datasets for these experiments means I cannot independently verify the claimed distinct species-like head shapes, thus the verdict is `needs-new-data`.

**Re-evaluating Data Gaps**

I'm currently reassessing the *Girardia* regeneration claims, specifically how they relate to gap junction disruption. The absence of publicly available raw bioelectric and morphometric data for these experiments means I cannot independently verify the claimed distinct head shapes, leading me to conclude these require new data.

**Assessing Bioelectric Data**

I'm analyzing claims concerning bioelectric effects and gap junctions in *Girardia* regeneration. The lack of publicly accessible datasets for MS washout, dye-coupling assays, and DiBAC imaging for *G. dorotocephala* means I cannot verify these assertions, leading to a `needs-new-data` verdict.

**Testing Bioelectric Predictions**

I'm focusing on claim `levin-2015-girardia-15`. The prediction that shape outcomes are encoded in time-dependent bioelectric activity, rather than steady voltage distributions, requires new longitudinal bioelectric data. Therefore, this claim is classified as `needs-new-data`.

**Testing Remodeling Claims**

I'm now evaluating claim `levin-2015-girardia-16`. The concept of a "homeostatic parameter" driving remodeling after regeneration is operationalizable as returning to a wild-type centroid, but the necessary longitudinal morphometric data from days 10-30 is not publicly available, requiring new data.

**Validating Mechanism Claims**

I'm currently evaluating the planarian regeneration claims, specifically regarding gap-junction-dependent signals. While some transcriptomic data exists, testing the instructive signaling guiding neoblast migration and head-shape morphogenesis requires functional perturbation and live tracking not fully covered by public datasets. This suggests a `needs-new-data` verdict.

**Distinguishing Conceptual Claims**

I'm now analyzing `levin-2015-girardia-18`, which proposes a conceptual analogy. Since it frames the claim as a metaphor and doesn't specify testable statistical dynamics differentiating it from other coupled systems, I'm classifying it as `not-empirically-resolvable`.

**Testing Attractor Hypotheses**

I'm now examining claim `levin-2015-girardia-19`. While the hypothesis of bioelectric network attractors in morphospace is conceptually testable, the absence of recorded spatiotemporal bioelectric data and a quantitative model makes direct empirical verification impossible. This leads to a `needs-new-data` verdict.

**Assessing Bioelectric Landscape**

I'm now examining the planarian head patterns, framing them as free-energy outcomes. While the concept of bioelectric network dynamics and attractors is intriguing, the current claim relies on a qualitative schematic, not a quantitative definition of free energy or its measurement. Therefore, it's currently `needs-new-data` for empirical verification.

**Evaluating Free Energy Definition**

I'm now examining claim `levin-2015-girardia-20`. The concept of bioelectric network attractors as free energy landscapes is circular as currently defined; the "free energy" is effectively derived from the stability of the observed morphologies themselves. Without an independent biophysical definition and measurement of this energy functional, the claim is either `not-empirically-resolvable` or `needs-new-data`.

**Testing for Definitional Claims**

I'm now evaluating `levin-2015-girardia-20`. The claim that bioelectric network attractors represent free energy landscapes, as currently defined, appears circular. Without an independent biophysical definition of this energy functional, the claim's empirical testability is limited, leaning towards `not-empirically-resolvable` or `needs-new-data`.

**Assessing Species-Specific Dynamics**

I'm evaluating the claim regarding distinct species-like head shapes arising from gap junction inhibition. Since the paper only presents data for one species (*G. dorotocephala*) and the raw data is unavailable, the comparative genomic analysis of GRN and innexin conservation is only partially resolvable. Further species-specific perturbation experiments are needed, classifying it as `needs-new-data`.

**Testing Embodied Claims**

I'm evaluating the claims from the `2014-tumor` paper. My current focus is on identifying raw experimental data, such as embryo images, ITLS counts, pH measurements, or FUCCI counts, which are not publicly available. This data gap necessitates classifying these claims as `needs-new-data`.

**Investigating Tumor Formation**

I'm currently analyzing the *Xenopus laevis* tumor formation claims. For claim `levin-2014-tumor-01`, the lack of public embryo-level scoring and Vmem recording datasets necessitates new experiments to verify the role of resting membrane potentials.

**Testing Tumor Incidence Claims**

I'm now examining claim `levin-2014-tumor-03`, which suggests a reduction in tumor incidence with Kv1.5 misexpression. The raw embryo-level scoring data needed to verify this quantitative effect is not publicly available, so this claim requires new experiments.

**Reaffirming Data Gaps**

I'm currently re-evaluating the experimental data requirements for *Xenopus laevis* tumor claims. For both `levin-2014-tumor-03` and `levin-2014-tumor-04`, the absence of raw embryo-level scoring and voltage data necessitates new experiments to verify the reported incidence reductions.

**Validating CLIC1 and HDAC1 Claims**

I'm now focused on claims regarding CLIC1's role in tumor suppression and HDAC1 activity as a transduction step. The lack of publicly available raw data for embryo scoring and voltage recordings for CLIC1, and raw data for HDAC1 activity, means both require new experiments.

**Checking Perturbation Data**

I'm assessing claim `levin-2014-tumor-07`. The provided data on antibiotic treatments impacting tumor incidence lacks raw embryo counts and evidence of the bacteria's role in restraining tumor formation. This necessitates new experiments for validation.

**Reconfirming Data Gaps**

I'm continuing to assess the *Xenopus laevis* tumor claims, specifically for `levin-2014-tumor-07` and `levin-2014-tumor-08`. The absence of raw embryo-level scoring, ITLS counts, and detailed Vmem data, alongside unpublished butyrate and microbiome sequencing data, indicates new experiments are necessary.

**Testing Tumor Predictions**

I'm currently assessing claim `levin-2014-tumor-09`. This involves evaluating the speculative prediction of bidirectional bioelectric communication in tumorigenesis. My analysis indicates that verifying this bidirectional signaling requires new spatiotemporal voltage mapping experiments, thus it is `needs-new-data`.

**Updating Tumor Claims**

I'm reassessing the *Xenopus laevis* tumor claims. For `levin-2014-tumor-09`, while the conceptual link between membrane potential changes and tumor incidence is strong, the lack of deposited perturbation data and the indirect nature of TCGA data prevent a direct empirical test of invariance across ion species. I'm leaning towards `needs-new-data`.

**Assessing Bacterial Distribution**

I'm currently evaluating claim `levin-2014-tumor-11`, which posits specific spatial dynamics for butyrate-producing bacteria. The authors acknowledge the lack of in vivo data on bacterial location and butyrate concentration, meaning this claim is currently `needs-new-data`.

**Testing Mammalian Cancer Claims**

I'm now evaluating claim `levin-2014-tumor-12`. This prediction about modulating resting membrane potential for cancer therapy in mammals is conceptually interesting, but testing the "remote endogenous bioelectric states" aspect in vivo necessitates new data, hence it's classified as `needs-new-data`.

**Updating Tumor and HCN2 Claims**

I'm currently assessing the *Xenopus laevis* tumor claims, particularly focusing on the lack of remote endogenous bioelectric state data for mammalian cancer, leading to a `needs-new-data` verdict. I've also begun analyzing claim `levin-2018-hcn2-01`, which details nicotine-induced brain defects in *Xenopus laevis* embryos.

**Revising Data Verdicts**

I'm currently reassessing the *Xenopus laevis* tumor claims and the HCN2 claims. For the tumor claims, the lack of raw data and unpublished results means new experiments are required. For the HCN2 claim, specific embryo scoring data under nicotine perturbation is missing, thus also requiring new data.

**Simulating Membrane Potentials**

I'm actively simulating the *Xenopus laevis* neurula model using the BETSE software. My current focus is on parameterizing the model with published ion concentrations and permeabilities to directly test the claim regarding regional membrane potential differences and compare them against empirical data.

**Verifying Simulation Claim**

I've determined that claim 15, pertaining to membrane potential differences in the *Xenopus* neurula BETSE model, is `resolvable-now` given the public availability of the BETSE software and model parameters. I am now proceeding to confirm all candidate dataset URLs for accuracy and accessibility.

_Tools used: Read ×8, UpdateCurrentStep ×3_

### 2026-10-31 14:38 — Turn 2 (User)

> Your previous run ended with an error before finishing. Continue the same task from your original instructions: score every claim in your input batch per INSTRUCTIONS.md and write the complete JSON array to your assigned output path. Do not write any other file. Reply with the output path, the claim count and the verdict counts.

_Tools used: UpdateCurrentStep_

_Turn ended: error ([unavailable] Error)_
